Improving Treatments for Advanced Prostate Cancer
Targeting Polo-Like Kinase 1 in Prostate Cancer to Enhance Therapeutic Efficacy
This project looks for new ways to treat advanced prostate cancer that has stopped responding to standard hormone therapy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-11110340 on NIH RePORTER |
What this research studies
Prostate cancer is a serious health concern for men, especially when it becomes resistant to initial hormone treatments. Current options for this advanced stage, called castration-resistant prostate cancer (CRPC), offer limited survival benefits. This project aims to find new drug targets and strategies to improve treatment for CRPC patients. Researchers are exploring a specific pathway involving Plk1, p62, and Nrf2, believing that blocking this pathway could make current therapies more effective.
Who could benefit from this research
Good fit: This research is focused on understanding and treating castration-resistant prostate cancer, which affects men whose prostate cancer has progressed despite hormone therapy.
Not a fit: Patients with early-stage prostate cancer or those whose cancer still responds well to hormone therapy may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new and more effective treatment options for men with advanced prostate cancer that is no longer responding to hormone therapy.
How similar studies have performed: This project explores a novel molecular mechanism involving the Plk1/p62/Nrf2 pathway, representing a new and untested approach for CRPC therapy.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Li, Zhiguo — University of Kentucky
- Study coordinator: Li, Zhiguo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.